Platelet‐Derived Extracellular Vesicles Alleviate Psoriatic Inflammation via Mitochondrial Transfer to Macrophages
Experimental Dermatology · 2025-08 · 34 (8)
DOI: 10.1111/exd.70152 ↗At a glance
Journal article in Experimental Dermatology, published online on 2025-08-17. Written by Bing Wang and 9 co-authors. Institution: Department of Dermatology, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. Major MEDLINE topics: Psoriasis, Extracellular Vesicles, Mitochondria, Macrophages. Cited 9 times so far (Crossref); 46 references. Funded by: National Natural Science Foundation of China, Natural Science Foundation of Shanghai, CSBT Scientific Research Programs Funded by WEGO.
Abstract (original language)
Platelet‐rich plasma ( PRP ) is a safe, autologous plasma component abundant in cytokines and extracellular vesicles, frequently applied to treat inflammatory disorders. Although PRP demonstrates potential for psoriasis therapy, its underlying mechanism remains insufficiently understood. In this study, various PRP constituents were evaluated in an imiquimod ( IMQ )‐induced mouse model of psoriasis. PRP , platelet‐derived extracellular vesicles ( PEVs ), and platelet‐poor plasma ( PPP ) were isolated from mice and administered subcutaneously. The data showed that PEVs , rather than PPP , served as the principal anti‐psoriatic factor. Furthermore, RNA sequencing and flow cytometry revealed that PEVs markedly suppressed M1 polarisation of macrophages, thereby mitigating psoriatic‐like inflammation. In vitro, PEVs delivered encapsulated mitochondria to RAW264 .7 cells in a concentration‐dependent manner. These functional organelles enhanced oxidative phosphorylation and suppressed glycolysis, driving a metabolic shift favouring an anti‐inflammatory phenotype and attenuating the inflammatory response. In conclusion, PEVs emerge as the primary PRP component responsible for inflammatory suppression in psoriasis. Notably, mitochondria transfer mediated by PEVs underscores a promising therapeutic avenue and provides novel insight into the role of platelet derivatives in inflammatory diseases.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Dermatology, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
- Institute of Dermatology, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
- Department of Transfusion Medicine, Huashan Hospital Affiliated to Fudan University, Shanghai, China.
ORCID profiles: Bing Wang, Dandan Li, Yumeng Wang, Yidong Tan, Yijun Yang, Haifei Liu, Zhirong Yao
Funding
- National Natural Science Foundation of China
- Natural Science Foundation of Shanghai
- CSBT Scientific Research Programs Funded by WEGO
Cite
APA
Wang, B., Li, D., Pan, C., Wang, Y., Tan, Y., Yang, Y., Liu, H., Yao, Z., Zhang, H., & Wang, Z. (2025). Platelet‐Derived Extracellular Vesicles Alleviate Psoriatic Inflammation via Mitochondrial Transfer to Macrophages. Experimental Dermatology, 34(8). https://doi.org/10.1111/exd.70152
Vancouver
Wang B, Li D, Pan C, Wang Y, Tan Y, Yang Y, et al. Platelet‐Derived Extracellular Vesicles Alleviate Psoriatic Inflammation via Mitochondrial Transfer to Macrophages. Experimental Dermatology. 2025;34(8). doi:10.1111/exd.70152
BibTeX
@article{Wang2025,
author = {Wang, Bing and Li, Dandan and Pan, Chaolan and Wang, Yumeng and Tan, Yidong and Yang, Yijun and Liu, Haifei and Yao, Zhirong and Zhang, Hui and Wang, Zhicheng},
title = {Platelet‐Derived Extracellular Vesicles Alleviate Psoriatic Inflammation via Mitochondrial Transfer to Macrophages},
journal = {Experimental Dermatology},
year = {2025},
volume = {34},
number = {8},
doi = {10.1111/exd.70152}
}
EUVIMED